Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes
about
A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virusEvolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targetsConsequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses.Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity.Influenza B virus requires BM2 protein for replicationThe early expression of glycoprotein B from herpes simplex virus can be detected by antigen-specific CD8+ T cells.Selective incorporation of influenza virus RNA segments into virions.A seven-segmented influenza A virus expressing the influenza C virus glycoprotein HEFPostexposure vaccination massively increases the prevalence of gamma-herpesvirus-specific CD8+ T cells but confers minimal survival advantage on CD4-deficient mice.A highly optimized DNA vaccine confers complete protective immunity against high-dose lethal lymphocytic choriomeningitis virus challenge.A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitopeAttenuated Mengo virus: a new vector for live recombinant vaccines.Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virusRNA virus vectors: where are we and where do we need to go?Characterization of a neuraminidase-deficient influenza a virus as a potential gene delivery vector and a live vaccine.Engineering influenza viral vectorsRecombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virusNegative-strand RNA viruses: genetic engineering and applications.Viruses - from pathogens to vaccine carriersRecombinant influenza viruses as delivery vectors for hepatis B virus epitopes.Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes.Replication-incompetent rabies virus vector harboring glycoprotein gene of lymphocytic choriomeningitis virus (LCMV) protects mice from LCMV challenge.
P2860
Q28740740-B6071585-ECA5-425D-A672-0655F9F3ECEAQ30366017-F45CCE86-9AF8-425A-96C9-DD0047A95C90Q33707307-83D4062B-325E-448D-BD6A-ED73895EA973Q33785966-D00DD76D-9556-4BA7-B935-7FAA57A1BCF1Q33908690-4C4978D2-F2CB-4C94-8DDB-CA6A124C86FDQ34150785-D1A0E4B8-EFD8-496F-ACDF-2262A9DA0B6BQ34472265-24025CBD-797E-414B-B17B-4819BF27FB2BQ34762920-D9E355A8-3C20-4910-B8F3-8B3F76F5EF95Q34775136-D069F7C3-FE0A-47DC-ADA3-35B9DCD76FE2Q35079839-926FD604-D261-41B8-A3FF-8B07CE8BE533Q35196530-D96F5896-29CB-4AF2-9F8F-BF7AF9FBDA1FQ35601591-D26766C4-E08E-401B-AD09-22F2D7328687Q35839164-2CFD43EB-7284-46C3-99B9-C4CF177B8B4DQ35849627-E08DD8E3-7B17-4581-A2A2-530EA46933C1Q36080373-E1F4B215-7A7D-4B31-952F-9A2AFF514E1DQ36509477-CB308A6E-970D-4395-9F71-4EA8D536AA2DQ36591871-A0A2B1AA-8033-4F31-8E11-633EB55C3544Q36659320-C30BD638-396B-48F7-9A21-34B46B34719AQ36667922-559889EA-18D0-4B8D-9D0F-DA774331BDD3Q36943971-00A953F1-7C55-410B-80C9-FEF9F246A99BQ37249720-046053FE-E4B5-418D-AAEF-14955F980D01Q37946370-EE9C8474-0AE1-4502-A26E-D6DCE5540758Q39770989-131D8A69-D50F-4A34-B619-E2143924B6C2Q39868823-0B924457-D3B8-4FB0-9388-E1EBB6515A19Q52586088-AA067536-80AC-41DB-B0D0-BB6DF62876C4
P2860
Protection against lethal lymphocytic choriomeningitis virus (LCMV) infection by immunization of mice with an influenza virus containing an LCMV epitope recognized by cytotoxic T lymphocytes
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Protection against lethal lymp ...... zed by cytotoxic T lymphocytes
@ast
Protection against lethal lymp ...... zed by cytotoxic T lymphocytes
@en
type
label
Protection against lethal lymp ...... zed by cytotoxic T lymphocytes
@ast
Protection against lethal lymp ...... zed by cytotoxic T lymphocytes
@en
prefLabel
Protection against lethal lymp ...... zed by cytotoxic T lymphocytes
@ast
Protection against lethal lymp ...... zed by cytotoxic T lymphocytes
@en
P2093
P2860
P921
P1433
P1476
Protection against lethal lymp ...... zed by cytotoxic T lymphocytes
@en
P2093
P2860
P304
P407
P577
1994-06-01T00:00:00Z